DERM: חוב לטווח קצר של החברה Journey Medical Corp

Journey Medical (DERM) focuses on the dermatological sector, driving growth through the implementation of rosacea therapy and the successful promotion of acne treatments amid expanding insurance coverage. The business relies on physician loyalty, attracting new clients with specialized FDA-supervised medications. The current metric is 0.01. This price action chart below demonstrates the market volatility of the company's shares.

Short-term debt measures the total liabilities with a maturity of up to one year, determining current liquidity and default risk. By analyzing a company's short-term debt, an investor assesses the firm's ability to service operational loans. Stable commercialization of dermatological products in the US provides Journey Medical (DERM) with the resources to meet these payments. Patent protection of formulas guarantees sustainable margins, confirming the high financial stability of the asset.